a Supplementary Figure 1. Supplementary Fig. 1 related to Fig. 1. LSD1 is expressed during brain development and LSD1 knockdown does not induce obvious apoptosis. (a) Immunostaining of coronal rat cortical sections at E20.5 with LSD1 antibody. Nuclei were labeled with DAPI. Scale bars, 50μm. (b) Brain slices (E20.5) electroporated with control or shL-1 at E16.5 were immunostained with activated-caspase3 antibody to label cells undergoing apoptosis. Scale bar = 50 μm. LSD1 DAPI Merge Ctrl shL-1 b DsRED Caspase3 DAPI c a b GFP α-Tub LSD1 hLSD1(mut) Supplementary Figure 2.
. LSD1 knockdown induced NPC depletion can be rescued by synonymously mutated human LSD1. (a) Coronal sections of rat brains electroporated with LSD1 shRNA (shL-1) together with pCAGIG-GFP or pCAGIG-hLSD1(mut) at E16.5 and inspected at E20.5. Scale bars, 50μm. (b) Quantification of cell distribution in (a). Data are means±SEM. ***: P<0.001. One-way ANOVA. shCtrl: n=26/8; shL-1+GFP: n=8/3; shL-1+hLSD1: n=10/3. n: number of brain slices from different brains.
(c) PCAGIG-hLSD1(mut) (synonymously mutated human LSD1) were cotransfected with control shRNA (shCtrl) or shL-1 into HEK293 cells and analyzed as in Fig. 1b,c. (d) Rescue experiments were done as in (a) and analyzed as in (Fig.2a ). Data are means±SEM. **P<0.01; ***P<0.001. Ctrl (Sox2: n=7/5; Tbr2: n=5/5; Tuj1: n=7/5); shL-1+pCAGIG (Sox2: n=3/3; Tbr2: n=3/3; Tuj1: n=3/3); shL-1+pCAGIG-mut-hLSD1 (Sox2: n=4/3; Tbr2: n=4/3; Tuj1: n=4/3). one-way ANOVA. n: number of brain slices from different brains. Scale bars, 50 μm.. Fig. 3 Supplementary Fig. 5 . related to Fig. 3 . LBAL, LSD1 binding site at the ATN1 locus, is conserved in rodents and humans. (a, b) Schematic illustration of sequence alignment of LBAL site from human, rat and mouse. Blast results showed that 85% nucleotides of one part of rat LBAL site are identical to those of mouse LBAL site (1108 out of 1306 nucleotides are the same). Two major parts of LBAL site (a and b) are homologues between human and rat. 244 out of 297 nucleotides in (a) and 227 out of 328 nucleotides in (b) are identical. The letters highlighted in black color showed that human, rat and mouse share the same nucleotides there. a b Supplementary Fig. 6 related to Fig. 3 . Knockout or knockdown of LSD1 leads to downregulation of ATN1 level. (a,b) Immunostaining of coronal cortical sections from E19.5 rat brain electroporated with Ctrl or shL1 at E16.5 with LSD1 (a) or ATN1(b) antibody. For each cortex, the fluorescence intensity of 5~10 DsRED+ cells in VZ was quantified and the average was used to represent as the levels of LSD1 or ATN1 of this cortex. Then the levels of LSD1 or ATN1 in shRNA group were normalized to that of shControl group. Nuclei were labeled with DAPI. *P=0.01 (LSD1), *P=0.02 (ATN1). LSD1 (Ctrl: n=3/3; shL1: n=3/3); ATN1 (Ctrl: n=3/3; shL1:n=3/3); Student's t-test. n: number of brain slices from different brains. Scale bar: 5μm. (c,d) Immunostaining of coronal cortical sections from wild-type or brain-specific LSD1-cKO mice at P0 with ATN1 antibody. Nuclei were labeled with DAPI. Data are means ± SEM. *P<0.05; **P<0.01; ns, not significant. (WT: n=6/3; cKO: n=6/3; one-way ANOVA). Scale bar: 20μm. Supplementary Fig. 12. Original WB images. (a) Original WB images of Fig.1b. (b) Original WB images of Fig.1c. (c) Original WB images of Fig.3f. (d) Original WB images of Fig.3h. (e) Original WB images of Fig.5c. (f) Original WB images of Supplementary Fig. 2c. (g) Original WB images of Supplementary Fig. 7b. (h) Original WB images of Supplementary Fig. 7c. (i) Original WB images of Supplementary Fig. 11a . Molecular weight markers are represented is kDa. IB: immunoblot. 
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